Abstract
The widespread deposition of amyloid plaques is one of the hallmarks of Alzheimer disease (AD). A recently described component of amyloid plaques is the 35-residue peptide, non-A beta component of AD amyloid, which is derived from a larger intracellular neuronal constituent, alpha-synuclein. We demonstrate that transglutaminase catalyses the formation of the covalent non-A beta component of AD amyloid polymers in vitro as well as polymers with beta-amyloid peptide, the major constituent of AD plaques. The transglutaminase-reactive amino acid residues in the non-A beta component of AD amyloid were identified as Gln79 and Lys80. Lys80 is localized in a consensus motif Lys-Thr-Lys-Glu-Gly-Val, which is conserved in the synuclein gene family. Thus transglutaminase might be involved in the formation of insoluble amyloid deposits and participate in the modification of other members of the synuclein family.
Keywords
Tissue transglutaminasePeptideAmyloid (mycology)P3 peptideChemistryBiochemistryBACE1-ASBiochemistry of Alzheimer's diseaseSenile plaquesAmyloid precursor proteinAlpha-synucleinPeptide sequenceIntracellularAmyloid betaAlzheimer's diseaseEnzymeGeneDiseaseMedicinePathologyParkinson's diseaseTransgeneGenetically modified mouse
Affiliated Institutions
Related Publications
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
A neuropathological hallmark of Alzheimer disease (AD) is a widespread amyloid deposition. We analyzed the entire amino acid sequences in an amyloid preparation and found, in ad...
Neuropathology of synuclein aggregates
Beginning with the isolation of the fragment of alpha-synuclein (alpha-syn) known as the non-Abeta component of amyloid plaques (NAC peptide) from Alzheimer's disease (AD) brain...
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology. The presence of extracellular β-amyloid deposition as neuritic plaques and intracellular acc...
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Amyloid beta-peptide (A beta) deposition in senile plaques and cerebral vessels is a neuropathological feature of Alzheimer disease (AD). We examined the possibility that common...
Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Accumulation of amyloid-beta (Abeta) is one of the earliest molecular events in Alzheimer disease (AD), whereas tau pathology is thought to be a later downstream event. It is no...
Publication Info
- Year
- 1995
- Type
- article
- Volume
- 310
- Issue
- 1
- Pages
- 91-94
- Citations
- 96
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
96
OpenAlex
Cite This
Poul Henning Jensen,
Esben S. Sørensen,
Torben E. Petersen
et al.
(1995).
Residues in the synuclein consensus motif of the <i>α</i>-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid <i>β</i>A4 peptide.
Biochemical Journal
, 310
(1)
, 91-94.
https://doi.org/10.1042/bj3100091
Identifiers
- DOI
- 10.1042/bj3100091